Package leaflet: Information for the user. Catephen 10% Ointment. Extract from green tea leaves

Similar documents
What you need to know about EGW

Package leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the patient. Avodart 0.5 mg soft capsules dutasteride

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Monovo 1 mg/g ointment. Mometasone furoate

ANDROGEL 50 mg, gel in sachet Testosterone

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the patient

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tacrolimus 0.1% Ointment Tacrolimus

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Gyno-Pevaryl Once 150mg vaginal pessary

2. What you need to know before you use TESTOGEL

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. Mometasone furoate 0.1%w/w Ointment (mometasone furoate)

PATIENT INFORMATION LEAFLET. Urea 10% w/w Cream

Package leaflet: Information for the user. Tremfya 100 mg solution for injection in pre-filled syringe guselkumab

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

Package leaflet: information for the user

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the patient

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Actikerall 5 mg/g mg/g Cutaneous Solution. Fluorouracil + Salicylic acid

1. What Faslodex is and what it is used for

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package leaflet: Information for the user

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

2 What you need to know before you use Zofran Suppositories

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user

Package leaflet: Information for the user

1. What Ursofalk 250mg hard capsules are and what they are used for

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package Leaflet: Information for the user

Package leaflet: Information for the user

Package leaflet: Information for the user. CLARELUX 500 microgram/g cutaneous foam in pressurised container (Clobetasol propionate)

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

Package leaflet: Information for the patient. IsotrexIN Gel erythromycin 2% and isotretinoin 0.05%

Package leaflet: Information for the user. Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin

Package leaflet: Information for the patient. Eczibet 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Hydrocortisyl Skin Cream 1% Hydrocortisone

Package leaflet: Information for the patient. Valotix 500 mg Film-Coated Tablets Valaciclovir

Package leaflet: Information for the user. Salofalk 3g gastro-resistant prolonged-release granules. Mesalazine

Benylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

PACKAGE LEAFLET: INFORMATION FOR THE USER. AVAXIM, Suspension for injection in a pre-filled syringe Hepatitis A vaccine (inactivated, adsorbed)

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

ALDARA 5% Cream PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT ALDARA CREAM IS AND WHAT IT IS USED FOR

Package Leaflet: Information for the user. TARGAXAN 550 mg film-coated tablets rifaximin

The medicines you are using mixed with Water for injections may interact with each other.

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

ANBESOL TM Anaesthetic Antiseptic Oromucosal solution Lidocaine hydrochloride 0.90%w/w, Chlorocresol 0.10%w/w, Cetylpyridinium Chloride 0.

Patient Information Leaflet

Package leaflet: Information for the user. Monovo 1 mg/g cutaneous emulsion. mometasone furoate

PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Transcription:

Package leaflet: Information for the user Catephen 10% Ointment Extract from green tea leaves Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Catephen is and what it is used for 2. What you need to know before you use Catephen 3. How to use Catephen 4. Possible side effects 5. How to store Catephen 6. Contents of the pack and other information 1. What Catephen is and what it is used for Catephen is a herbal medicinal product for skin use only. Its active substance is an extract from green tea leaves. Catephen is used to treat warts (Condylomataacuminata) on the surface of the genitals (sexual organs) and around the anus. Catephen is used in adults with normal function of their immune system. You should talk to a doctor if you feel worse, or do not feel better after 4-6 weeks of treatment. 2. What you need to know before you use Catephen Talk to your doctor before using Catephen. Do not use Catephen - If you are allergic (hypersensitive) to green tea extract or any of the other ingredients of this medicine (listed in section 6.Contents of the pack and other information ). Warnings and precautions - Talk to your doctor if you have any problems with your liver or immune system. Catephen should not be used if your liver function is impaired (e.g. abnormal accumulation of fluid in the abdomen, yellow skin due to liver dysfunction) or when your immune system is compromised (either due to illness or due to other medicines you are taking). - Do not use Catephen until the area to be treated has completely healed after previous drug or surgical treatment. - Avoid contact with the eyes, nostrils, lips and mouth. If the ointment gets on any of these areas inadvertently, it should be wiped off and/or rinsed off with water. - Do not apply to open wounds, broken or inflamed skin. 1

- Catephen must not be applied on mucous membranes, so it is not a treatment for warts in the vagina, cervix, urethra or inside the anus. - Female patients with genital warts in the vulvar region should use the ointment with caution as treatment in this area can cause severe local adverse reactions more often. - Uncircumcised male patients treating warts under the foreskin should retract the foreskin and clean the area daily to prevent phimosis (when the foreskin cannot be pulled back over the head of the penis). When early signs of stricture occur (e.g. open sores, hardening of the skin or increasing difficulty in retracting the foreskin), you should stop the treatment and consult your doctor. - Catephen does not eliminate the HPV-virus or prevent transmission of the disease, therefore special care should be taken before sexual activity; see section 3. How to use Catephen of this leaflet. - In case your sexual partner is infected with genital warts his/her treatment is advisable and will help to prevent reinfection. You can ask your doctor for advice. - Do not expose the treated area to sunlight and do not use sunlamps and tanning beds. - Catephen stains clothing and bedding. - Mild local skin reactions such as redness, itching, irritation (mostly burning), pain and swelling at the site of application are very common and should not lead to discontinuation. They should decrease after the first weeks of treatment; see section 4. Possible side effects. Children and adolescents Catephen is not recommended for use in children and adolescents below the age of 18 years. Other medicines and Catephen Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine or if you have recently had other treatments for warts around the sexual organs or the anus. Catephen should not be used together with other treatment at the wart area. Catephen should not be used until your skin has healed from other treatments. Catephen with food and drink There is no interaction with food and drink. As a precaution to avoid interactions / side effects, Catephen should not be used with food supplements containing high amounts of extract from green tea leaves. Pregnancy, breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Pregnancy There are no or limited data available on the use of Catephen in pregnant women. Reproductive studies in animals have shown toxic effects. Therefore as a precautionary measure, although exposure to epigallocatechingallate (the main constituent of green tea) is expected to be low following application to the skin, the use of Catephen during pregnancy should be avoided. (see section 3. How to use Catephen ). Breast-feeding It is not known if Catephen or its metabolites are excreted in breast milk and therefore it is not known if there is a risk to a breast-fed baby. However following application of the product to the mothers skin, the risk of adverse effects in the breast-fed baby are likely to be low. Fertility There is no evidence of an effect on fertility if you use Catephen as prescribed. Driving and using machines 2

No studies on the effect on the ability to drive and use machines have been performed. However it is unlikely that treatment will have an effect on the ability to drive or use machines. Catephen contains isopropyl myristate and propylene glycol monopalmitostearate Catephen contains, among other ingredients, high amounts of isopropylmyristate (IPM), which can cause irritation and sensitization of the skin, and propylene glycol monopalmitostearate which may cause skin irritations. 3. How to use Catephen Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is up to 0.5 cm of ointment strand (corresponding to 250 mg) for all warts together, applied three times daily (in the morning, at mid-day and in the evening). - Wash hands before and after applying the ointment. - Apply a small amount of Catephen to each wart using the fingers, dabbing it on to ensure complete coverage and leaving a thin layer of the ointment on the warts Do not apply the ointment internally (into the anus, urethra or into the vagina). - Do not cover the treated area with bandages after you have applied the ointment. - It is not necessary to wash off the ointment from the treated area prior to the next application. When you wash the treatment area or bathe, apply the ointment afterwards. - Apply Catephen three times per day (in the morning, at mid-day and in the evening). - New warts may develop during treatment, which need to be treated in the same way. - Genital warts are a sexually transmitted disease; therefore you may infect your partner by sexual activity. Condoms should be used until complete clearance of all warts. The use of condoms prevents reinfection as well. - Catephen may weaken condoms and vaginal diaphragms. Before sexual activity, wash off the ointment carefully with warm water and mild soap and apply a condom thereafter. Ask your doctor for additional methods of contraception. - Female patients during menstruation using tampons: insert the tampon before applying the ointment. If you need to change your tampon while the ointment is on your skin, avoid getting the ointment into the vagina. In case of accidental application immediately wash-off the ointment with warm water and mild soap. - Duration of treatment with Catephen should be continued until complete clearance of all warts, however no longer than 16 weeks, even if new warts develop during the treatment period. If the warts do not go away or if they come back after treatment please consult your doctor. Use in children and adolescents (below the age of 18 years) Catephen is not approved for use in children and adolescents below the age of 18 years. Older people There is limited experience for the use of Catephen in older people. Hepatic impairment You should not use Catephen if your liver function is impaired (e.g. abnormal accumulation of fluid in the abdomen, yellow skin due to liver problems). If you use more Catephen than you should You may experience more intense local reactions (see sections 2.What you need to know before you use Catephen and 4. Possible side effects ). Wash off the extra ointment with mild soap and water. If you have accidentally swallowed the ointment you should contact your doctor. If you forget to use Catephen 3

Continue next dose when it's due. Do not use a double dose to make up for a forgotten dose. If you stop using Catephen Clearance of warts may not be achieved. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. Possible side effects Like all medicines,this medicine can cause side effects, although not everybody gets them. Most of the side effects of Catephen are due to its local action on the skin and occur on or around the treated wart area. Many patients experience redness, itching, irritation, pain or swelling. Mild reactions are expected and should ease after the first weeks of treatment. If however, the intensity of local skin reactions is affecting your daily activities or if blisters occur, please consult your doctor. It may be necessary to interrupt treatment. Treatment can be resumed after the skin reaction has subsided. In case of vesicular local reactions please consult your doctor. If you experience severe local reaction causing unacceptable discomfort e.g. local inflammation/infection, open sore, swelling of lymph nodes or any other serious reaction (e.g. constriction of foreskin or urethra, difficulty passing urine or severe pain) you should stop treatment, wash off the ointment with warm water and mild soap and consult your doctor straight away. For the assessment of the side effects the following frequency rating was used: Very common Common Uncommon may affect more than 1 in 10 people may affect up to 1 in 10 people may affect up to 1 in 100 people Very common: - Local skin reactions at the wart site where you have applied Catephen including: redness, itching, irritation/burning, pain, swelling, open sores, hardening of the skin, and blisters. Common: - Local skin reactions like flakiness, discharge, bleeding, swelling - Swelling of lymph nodes (in the groin) - Constriction of the foreskin of the penis Uncommon: - Local scarring, fissure, skin dryness, discomfort, erosion, increase or loss of sensation, nodule, papules, inflammation of the skin, and changes in skin colour at the application site, local necrosis, eczema - Pustules at the application site, infections at the application site, genital herpes infection, staphylococcal infection, fungal infection of the vagina, inflammation of the urethra or of the vulva and vagina - Pain, high frequency or urgency in urinating - Inflammation of the foreskin and head of the penis, painful sexual intercourse - Rash, hypersensitivity Adverse reactions that were observed with a higher strength (Catephen 15%) ointment only: - Bacterial skin infections (pyoderma), inflammation of vulva - Constriction of the urethra/difficulty passing urine, vaginal discharge Reporting side effects If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via 4

IRELAND HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie UK Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Catephen Keep this medicine out of the sight and reach of children. Do not store above 25 C. Use within 6 weeks after first opening of the tube Do not use this medicine after the expiry date which is stated on the tube and carton label after {EXP}. The expiry date refers to the last day of that month. Do not throw away any medicine via wastewater or houshold waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Catephen contains The active substance is an extract from green tea leaves. 1 g of the ointment contains 100 mg of extract (as dry extract, refined) from Camellia sinensis (L.) O. Kuntze, folium (green tea leaf) (24-56:1), corresponding to: 55-72 mg of (-)-epigallocatechingallate. First extraction solvent: water The other ingredients are: white soft paraffin (contains all-rac-α-tocopherol), white beeswax, isopropyl myristate, oleyl alcohol, propylene glycol monopalmitostearate. What Catephen looks like and contents of the pack Catephen is a brown, smooth ointment, free from gritty particles presented in 2 tube sizes: 15 g and 30 g. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Kora Corporation Ltd t/a Kora Healthcare Swords Business Park, Swords, Co. Dublin, Ireland Manufacturer: Medigene AG 5

Lochhamer Strasse 11 D-82152 Planegg / Martinsried Germany This medicinal product is authorised in the Member States of the EEA under the following names: Austria: Veregen 10% Salbe Italy: Veregen Belgium: Veregen pommade Latvia: Veregen 100 mg/g ziede Bulgaria: Veregen 10% маз Lithuania: Veregen 100 mg/g tepalas Croatia: Veregen 100 mg/g mast Luxembourg: Veregreen 10 % Cyprus: Veregreen 10% Αλοιφή Netherlands: Veregen 10%, zalf Czech Veregen 10% mast Republic: Poland: Veregen 100 mg/g maść Estonia: Veregen Portugal: Veregen Romania: Veregen 100 mg/g unguent France: Veregen 10%, pommade Slovak Veregen 100 mg/g masť Republic: Germany: Veregen 10% Salbe Slovenia: Veregen 100 mg/g mazilo Greece: Veregreen 10%Αλοιφή Spain: Veregen 100 mg/g pomada Hungary: Veregen 10% kenőcs Ireland: Catephen United Kingdom: Catephen This leaflet was last revised in 07/2018 6